STOCK TITAN

Rocket Lab Corporation Announces Dollar-for-Dollar Replacement At-The-Market Equity Program

(Moderate)
(Neutral)
Tags

Rocket Lab (Nasdaq: RKLB) entered into a new equity distribution agreement with Deutsche Bank Securities and Wells Fargo Securities, allowing it to offer and sell common stock of up to $1,944,369,826 under an at-the-market (“ATM”) equity program. This agreement replaces a prior May 20, 2026 equity distribution agreement and carries forward only the remaining unsold amount, with no increase in the aggregate offering capacity. The prior agreement has been terminated.

Rocket Lab currently intends to use net proceeds from any ATM sales to help fund cash payments for its proposed Iridium Communications acquisition and to reduce commitments under its senior secured debt bridge facility. The ATM is not conditioned on closing the Iridium deal; if that transaction does not occur or proceeds exceed its needs, Rocket Lab may allocate funds to future growth, potential acquisitions, and general corporate and working capital purposes. Sales may be made from time to time on Nasdaq or otherwise, at prevailing, related, or negotiated prices, including via forward sale agreements, under the company’s effective automatic shelf registration on Form S-3ASR.

Loading...
Loading translation...

Positive

  • $1.94 billion ATM capacity preserved with no increase in aggregate amount
  • ATM proceeds can fund Iridium acquisition cash portion and reduce bridge debt commitments
  • Flexibility to redirect excess proceeds to growth, future acquisitions, and working capital

Negative

  • Potential share dilution from up to $1.94 billion of common stock sales
  • No assurance any shares will be sold, creating funding uncertainty for the Iridium acquisition

News Explained

The disclosed ATM amount is an available ceiling, not a completed financing: Rocket Lab says there can be no assurance that shares will be sold, so this release establishes no proceeds received or new-share dilution.

Market Reaction – RKLB

-2.67% $79.00 2.1x vol
15m delay
-2.67% Vs previous close
$79.00 Last Price
$76.67 $80.93 Day Range
$49.78B Market Cap
2.1x Rel. Volume

Following this news, RKLB has declined 2.67%, reflecting a moderate negative market reaction. Our momentum scanner has triggered 4 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $79.00. Trading volume is elevated at 2.1x the average, suggesting increased selling activity.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

A prior offering-related event recorded a 4.16% 24-hour move, while insider data showed Net Selling....
Analysis

A prior offering-related event recorded a 4.16% 24-hour move, while insider data showed Net Selling. The platform record adds financing precedent and governance context; watch reported ATM sales and updates on Iridium funding and completion conditions.

Key Figures

ATM offering amount: $1,944,369,826 Announcement date: Aug. 13, 2026 Prior agreement date: May 20, 2026 +3 more
6 metrics
ATM offering amount $1,944,369,826 Replacement equity distribution agreement
Announcement date Aug. 13, 2026 Rocket Lab announcement
Prior agreement date May 20, 2026 Agreement being replaced
Shelf registration filing date March 11, 2025 Form S-3ASR registration statement
File number 333-285707 Form S-3ASR registration statement
Missions in Earth orbit More than 1,700 missions Company description

Previous Offering Reports

1 past event · Latest: Apr 08 (Negative)
Same Type Pattern 1 events
Date Event Sentiment 24h Move Catalyst
Apr 08 ATM offering Negative +4.2% Company completed ATM sales and disclosed forward transactions for growth and acquisition funding.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The sole tag-specific comparator, a completed ATM offering, was followed by a positive 4.16% 24-hour move despite the offering category.

Key Terms

at the market, equity distribution agreement, forward sale agreements, automatic shelf registration statement, +1 more
5 terms
at the market financial
"pursuant to an “at the market” program (the “ATM Program”)"
“At the market” describes a method companies use to sell newly issued shares directly into the open market at whatever the current trading price is, usually through a broker who places shares in small amounts over time. Investors care because it can reduce each existing shareholder’s ownership percentage and increase the number of shares outstanding, while giving the company a flexible, quick way to raise cash — like adding single seats to a train instead of buying a whole new carriage.
equity distribution agreement financial
"entered into a replacement equity distribution agreement with Deutsche Bank"
An equity distribution agreement is a formal plan between a company and financial institutions to sell newly issued shares of the company's stock to investors over a period of time. It helps the company raise money gradually, similar to filling a container with water in stages, rather than all at once. For investors, it provides an organized way to buy shares and can influence the stock's supply and price.
forward sale agreements financial
"The equity distribution agreement also provides for certain forward sale agreements."
A forward sale agreement is a deal where two parties agree today to sell and buy an asset at a set price on a future date. It’s like promising to sell your car to a friend next month at today's price, regardless of how the car's value changes. These agreements help businesses lock in prices and reduce uncertainty about future costs or income.
automatic shelf registration statement regulatory
"pursuant to the Company’s automatic shelf registration statement on Form S-3ASR"
An automatic shelf registration statement is a pre-approved filing that companies submit to securities regulators, allowing them to sell new shares or bonds quickly and efficiently when needed. It acts like a standing permit, enabling the company to raise money without going through a lengthy approval process each time, which can be helpful for responding promptly to market opportunities or needs. For investors, it provides transparency about the company's ability to raise funds and signals planning flexibility.
prospectus supplement regulatory
"the prospectus supplement relating to the ATM Program"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

- New equity distribution agreement replaces the Company’s prior equity distribution agreement and provides for an aggregate offering amount equal to the remaining unsold amount; No increase in aggregate amount offered

- Company intends to use any net proceeds to fund a portion of the cash payments for the Iridium acquisition and reduce debt commitments

LONG BEACH, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or the “Company”), a global leader in launch services and space systems, today announced that it has entered into a replacement equity distribution agreement with Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC (the “equity distribution agreement”) under which it may offer and sell shares of its common stock (the “Shares”) having an aggregate offering price of up to $1,944,369,826 from time to time pursuant to an “at the market” program (the “ATM Program”). The equity distribution agreement replaces the Company’s prior equity distribution agreement dated May 20, 2026 (the “prior sales agreement”) carrying forward the unsold offering amount under that agreement. The Company has terminated its prior sales agreement. No additional Shares beyond the unsold offering amount is being offered under the ATM Program.

Rocket Lab currently intends to use all or a portion of the net proceeds from the sale of Shares under the ATM Program to fund cash payments under its previously announced proposed acquisition of Iridium Communications Inc. (the “Iridium Acquisition”) and reduce the commitments under its committed senior secured debt bridge facility. The Company also separately announced today additional updates on the Iridium Acquisition, including the expiration of the HSR waiting period, the initial filing of its Registration Statement on Form S-4 related to the transaction (which registration statement has not yet become effective), the filing of its FCC applications, and updates on its capital strategy for the Iridium Acquisition.

The offering of Shares under the ATM Program is not conditioned upon the completion of the Iridium Acquisition. If the Company does not consummate the Iridium Acquisition or if it has excess proceeds from the offering of Shares under the ATM Program, the Company intends to use the net proceeds to fund future growth, including potential future acquisitions, and for general corporate and working capital purposes.

Any sales of Shares under the ATM Program will be through Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC, as sales agents and/or principals, in “at the market” offerings, including on Nasdaq or otherwise, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. The equity distribution agreement also provides for certain forward sale agreements.

The offer and sale of Shares under the ATM Program will be made pursuant to the Company’s automatic shelf registration statement on Form S-3ASR (File No. 333-285707) originally filed with the SEC by the Company’s predecessor on March 11, 2025, as amended by post-effective amendment on May 27, 2025 and adopted by the Company. Prospective investors should read the prospectus contained in the registration statement and the prospectus supplement relating to the ATM Program (including the documents incorporated by reference therein) for more complete information about the Company and the ATM Program, including the risks associated with investing. Copies of the prospectus supplement and related prospectus may be obtained from Deutsche Bank Securities Inc., Attention: Prospectus Group, 1 Columbus Circle, New York, NY 10019, by telephone: (800) 503-4611, or by email: prospectus.cpdg@db.com; or Wells Fargo Securities, LLC, 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, Attention: WFS Customer Service, toll-free at 1-800-645-3751 (option #5) or email to WFScustomerservice@wellsfargo.com. You may also obtain these documents free of charge when they are available by visiting EDGAR on the SEC’s website at www.sec.gov.

There can be no assurance that the Company will sell any shares under the ATM Program. The timing of any sales and the number of shares sold, if any, will depend on a variety of factors to be determined by the Company.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer, solicitation or sale will be made only by means of the prospectus supplement and the accompanying prospectus.

About Rocket Lab

Rocket Lab (Nasdaq: RKLB) is an end-to-end space company delivering rockets, satellites, and spacecraft components for commercial, government, and defense missions. Driven by its industry-leading small-lift rockets Electron and HASTE and its upcoming reusable Neutron medium-lift rocket, Rocket Lab delivers reliable and responsive launch for the world’s most important missions from constellation deployment to missile defense. Rocket Lab’s satellites and components have powered more than 1,700 missions in Earth orbit, as well as deep-space exploration of the Moon, Mars, and beyond.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding the ATM Program and the use of proceeds of sales, if any, under the ATM Program, the proposed Iridium Acquisition and financing plans for the acquisition, our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at https://investors.rocketlabcorp.com which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Rocket Lab Media Contact
Murielle Baker
media@rocketlabusa.com


FAQ

What did Rocket Lab (RKLB) announce about its new at-the-market equity program on August 13, 2026?

Rocket Lab announced a replacement at-the-market equity distribution agreement allowing sales of common stock up to $1,944,369,826. According to Rocket Lab, this new agreement carries forward only the unsold capacity from a May 20, 2026 program and does not increase the aggregate offering amount.

How large is Rocket Lab’s (RKLB) at-the-market offering capacity under the new equity distribution agreement?

Rocket Lab may sell common stock with an aggregate offering price of up to $1,944,369,826 under the ATM. According to Rocket Lab, this amount reflects the remaining unsold balance from its prior equity distribution agreement, with no additional shares authorized beyond that unsold capacity.

Will Rocket Lab’s new ATM equity program dilute existing RKLB shareholders?

The program permits Rocket Lab to issue and sell new shares, which may dilute existing shareholders if fully utilized. According to Rocket Lab, sales can be made from time to time at prevailing or negotiated prices, up to the $1.94 billion aggregate capacity.

Is Rocket Lab’s at-the-market offering conditional on completing the Iridium acquisition?

The ATM equity program is not conditioned on closing the Iridium acquisition. According to Rocket Lab, if the Iridium deal is not consummated or proceeds exceed its needs, funds may instead support future growth, potential acquisitions, and general corporate and working capital purposes.

Who are the sales agents for Rocket Lab’s (RKLB) at-the-market equity offering and how will sales occur?

Deutsche Bank Securities and Wells Fargo Securities will act as sales agents and/or principals for the ATM. According to Rocket Lab, shares may be sold on Nasdaq or otherwise, at prevailing market prices, prices related to market levels, or negotiated prices, including via forward sale agreements.

Under what SEC registration does Rocket Lab’s (RKLB) ATM equity program operate?

The ATM program is conducted under Rocket Lab’s automatic shelf registration statement on Form S-3ASR (File No. 333-285707). According to Rocket Lab, investors should review the base prospectus and ATM prospectus supplement, including incorporated documents, for detailed information and related risk factors.